Karl Reich grew up in New York City and had an urban childhood. He received his undergraduate degree in Chemistry from Cornell University in rural Ithaca. He then worked in several laboratories as a technician, before going back to school and obtaining his doctorate in Molecular Biology from UCLA [through a quirk, his graduate research was performed at Harvard Medical School].
Dr. Reich’s postdoctoral training included work at the Institut Pasteur, Paris France and at Stanford Medical School in Stanford California. He then spent five years in the Pharmaceutical Division of Abbott Laboratories. This experience awakened his interest in the commercial opportunities of science. Subsequently he has worked in a number of biotech ventures all related to genomics, genetics and DNA. He is presently the Chief Scientific Officer of IFI where he oversees the laboratory and directs the research and development efforts.
Karl has more than 20 years of scientific experience in chemistry, molecular biology and biochemistry. He was originally trained as a chemist and an undergraduate degree from Cornell. His graduate training was in molecular biology at ULCA and Harvard Medical School. In addition he has significant post-doctoral training at Institut Pasteur (Paris) and at Stanford Medical School. Karl has industrial management experience from his years at Abbott Laboratories where he directed numerous molecular biology projects in anti-infectives and diabetes. He has published more than 20 research papers in first line scientific journals, and has received allowances on two molecular biology related patents.